Evaluation of disturbances in metabolism related to lipid profile in patients with schizophrenia

Moura, Lara; Moreira, Anabela; Ferreira, Stéphanie; Moreira, Teresa; Mota, Sandra; Marques, António; Amorim, Manuela

http://hdl.handle.net/10400.22/20181

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
POSTER_Lara Moura.pdf		378.23 KB	Adobe PDF	Download
license (2).txt		1.74 KB	License	Download

Send Feedback

Authors

Abstract(s)

Schizophrenia (SCZ) is a complex and multifactorial mental disorder. Currently, pharmacologic antipsychotic therapy (AP) focuses in SCZ symptoms minimization. AP has been associated with potentially adverse metabolic effects that may lead to an increased cardiovascular risk (CVR). To characterize SCZ patients of a psychosocial rehabilitation association (PRA) regarding antipsychotic therapy and sociodemographic, clinical, biochemical (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides) and anthropometric parameters; To describe the AP prescription when observed changes in biochemical parameters.

URI

http://hdl.handle.net/10400.22/20181

Citation

Moura, L., Moreira, A., Ferreira, S., Moreira, T., Mota, S., Marques, A., & Amorim, M. (2015). Evaluation of disturbances in metabolism related to lipid profile in patients with schizophrenia. In R. A. Silva, P. Baylina, F. Q. Vieira, C. Barrias, M. Rubim, T. Coelho, C. Prudêncio, & Â. Jesus (Eds.), II Congresso Internacional da Saúde Gaia Porto: Livro de Resumos (1st ed., Vol. 1, pp. 129). Escola Superior de Tecnologia da Saúde do Instituto Politécnico do Porto.